NCT07331493

Brief Summary

This study uses number and size of ovarian follicles on the day of ovulation trigger as key determinants for oocytes yield to optimize outcomes in IVF and ICSI Protocols

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
57mo left

Started Apr 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
4 months until next milestone

Study Start

First participant enrolled

April 30, 2026

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2030

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

3.7 years

First QC Date

November 21, 2025

Last Update Submit

February 9, 2026

Conditions

Keywords

ICSIFollicular sizeOocyte RetrievalOocyte yieldassisted reproduction

Outcome Measures

Primary Outcomes (1)

  • Total number of oocytes retrieved per participant during an ICSI cycle

    The total number of oocytes retrieved will be recorded for each participant. Follicular number and mean follicular diameter will be measured by transvaginal ultrasound during ovarian stimulation, and their association with oocyte yield will be analyzed to determine minimum predictive thresholds for successful oocyte retrieval.

    From the start of controlled ovarian stimulation until the day of oocyte retrieval, assessed at oocyte retrieval (approximately 10-14 days after stimulation initiation and 34-36 hours after ovulation trigger).

Secondary Outcomes (1)

  • Oocyte yield stratified by follicle size category and age group

    From the start of controlled ovarian stimulation until the day of oocyte retrieval, assessed at oocyte retrieval (approximately 10-14 days after stimulation initiation and 34-36 hours after ovulation trigger).

Study Arms (1)

ICSI observational Cohort

Participants will undergo standard ICSI procedures. Follicle size and number will be measured during ovarian stimulation; and oocyte yield will be see corded at retrieval. No additional interventions will be performed. The study aims to evaluate the predictive relationship between follicle characteristics and Oocyte yield

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female participants are eligible because the study focuses on Oocyte retrieval during ICSI, which is a procedure performed in women
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Female participants aged 18 to 35 years undergoing ICSI

You may qualify if:

  • women aged 18 to 35 years undergoing ICSI.
  • at least four follicles above 15 mm in diameter on the day of trigger
  • Downregulation using either GNRH antagonist or agonist protocol
  • Provision of written ,informed consent
  • BMI 18 to 35 kg per meter square

You may not qualify if:

  • anticipated poor responder, according to Bologna criteria
  • cycle canceled prior to retrieval or without trigger administration
  • Oocyte cryoperservation cycles or natural IVF cycles
  • presence of ovarian pathology affecting the follicular assessment (endometriosis,cysts )

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, Asyut Governorate, 71511, Egypt

Location

Related Links

MeSH Terms

Conditions

Infertility, Female

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertility

Study Officials

  • Alaa Ahmed Makhlouf, MD

    Assiut University

    STUDY CHAIR
  • Ahmed Abo-Elfadle, MD

    Assiut University

    STUDY CHAIR
  • Ahmed Mohamed Abo Elhasan Morsy, MD

    Assiut University

    STUDY CHAIR

Central Study Contacts

Ahmad Rashad Mahmoud Mostafa, MBBCh

CONTACT

Karima Sobhy M.Kholeif, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
7 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

November 21, 2025

First Posted

January 12, 2026

Study Start

April 30, 2026

Primary Completion (Estimated)

December 30, 2029

Study Completion (Estimated)

December 30, 2030

Last Updated

February 11, 2026

Record last verified: 2026-02

Locations